The book is a timely and insightful exploration into the complex intersection of intellectual property rights and the pharmaceutical industry amidst the global pandemic. Ms. Tiwari, through this book delves into the legal frameworks and challenges faced by pharmaceutical companies in safeguarding their innovations and proprietary interests while responding to the urgent demands for medical solutions during the COVID-19 crisis. Through a comprehensive analysis of intellectual property laws, including patents, trademarks, and copyrights, the book offers valuable perspectives on how regulatory mechanisms can both incentivize innovation and ensure equitable access to essential healthcare products. With its blend of legal scholarship and practical insights, this book serves as an indispensable resource for policymakers, legal practitioners, scholars, and stakeholders navigating the evolving landscape of pharmaceutical innovation in the context of public health emergencies.
